Helsinki University Central Hospital

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: Private

Established: 1958-03-01

Employees: 10K

Market Cap: -

Website: http://www.hus.fi

Clinical Trials

Best Practice in the Management of Concha Bullosa in FESS Operation

Not Applicable

Active, not recruiting

Conditions: Sinusitis
Sinusitis Bacterial
Sinusitis Recurrent
Turbinate; Hypertrophy Mucous Membrane
Turbinate Hypertrophy
Concha Bullosa
Middle Turbinate

First Posted Date: 2024-11-13

Last Posted Date: 2024-11-13

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 62

Registration Number: NCT06687629

Locations: 🇫🇮
Helsinki University Hospital Ear Clinic, Helsinki, Uusimaa, Finland

Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Intravaginal estrogen during adjuvant letrozole

First Posted Date: 2024-10-23

Last Posted Date: 2024-10-23

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 20

Registration Number: NCT06654570

Locations: 🇫🇮
HUS Comprehensive Cancer Center, Helsinki, Finland

Protective Ileostomy Versus Protective Colostomy in Anterior Rectal Resection

Not Applicable

Not yet recruiting

Conditions: Stoma Colostomy
Stoma Ileostomy

First Posted Date: 2024-10-21

Last Posted Date: 2024-10-21

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 350

Registration Number: NCT06650085

Locations: 🇫🇮
Helsinki University Hospital, Helsinki, Finland
🇫🇮
Tampere University Hospital, Tampere, Finland
🇫🇮
Turku University Hospital, Turku, Finland

'My Life is Music' Group Therapy Model - a Feasibility Study for Adolescents With Persistent Pain

Not Applicable

Not yet recruiting

Conditions: Pediatric Pain

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 24

Registration Number: NCT06576219

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

Not Applicable

Not yet recruiting

Conditions: Drug Interaction

Interventions: Drug: Caffeine Tablet
Drug: Bupropion Hydrochloride Capsels
Drug: Repaglinide Capsels
Drug: Flurbiprofen Capsels
Drug: Omeprazole 10 MG
Drug: Dextromethorphan Oral Solution
Drug: Midazolam oral solution
Drug: Simvastatin tablets
Drug: Placebo
Drug: Carvedilol
Drug: Diclofenac

First Posted Date: 2024-08-22

Last Posted Date: 2024-08-22

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 12

Registration Number: NCT06566794

Locations: 🇫🇮
Department of Clinical Pharmacology, Helsinki, Finland

Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans

Not Applicable

Conditions: Non-alcoholic Fatty Liver Disease NAFLD

Interventions: Diagnostic Test: 13C-α-Ketoisocaproic Acid Breath Test
Dietary Supplement: Ethanol
Dietary Supplement: Lipid Emulsion
Other: Normal Saline

First Posted Date: 2024-08-19

Last Posted Date: 2024-08-19

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 12

Registration Number: NCT06559878

Locations: 🇫🇮
Helsinki Central University Hospital, Helsinki, Uusimaa, Finland

Hair Cortisol and Symptoms in Children With Psychopathology During CBT

Not Applicable

Completed

Conditions: Child Behavior Problem

Interventions: Behavioral: The Friends Program

First Posted Date: 2024-02-23

Last Posted Date: 2024-02-29

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 100

Registration Number: NCT06274424

a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

Not Applicable

Active, not recruiting

Conditions: to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm

Interventions: Other: With radioiodine treatment
Procedure: With postoperative radioiodine treatment

First Posted Date: 2024-02-21

Last Posted Date: 2024-02-21

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 61

Registration Number: NCT06271044

KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution

Phase 1

Completed

Conditions: Psychosis
Food-drug Interaction

Interventions: Drug: Risperidone oral solution

First Posted Date: 2024-01-23

Last Posted Date: 2024-12-05

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 12

Registration Number: NCT06218979

Locations: 🇫🇮
Department of Clinical Pharmacology, Helsinki, Finland

Sleep and Neuropathic Pain - Intervention Study on Pregabalin

Not Applicable

Recruiting

Conditions: Insomnia
Neuropathic Pain
Sleep Disorder

Interventions: Drug: Pregabalin

First Posted Date: 2023-12-05

Last Posted Date: 2025-03-14

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 40

Registration Number: NCT06155916

Locations: 🇫🇮
Helsinki University Central Hospital, Helsinki, HUS, Finland
🇫🇮
Helsinki University Hospital, Department of Neurology, Helsinki, Uusimaa, Finland

AI-Powered Research

Premium Access

Helsinki University Central Hospital

Best Practice in the Management of Concha Bullosa in FESS Operation

Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

Protective Ileostomy Versus Protective Colostomy in Anterior Rectal Resection

'My Life is Music' Group Therapy Model - a Feasibility Study for Adolescents With Persistent Pain

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans

Hair Cortisol and Symptoms in Children With Psychopathology During CBT

a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution

Sleep and Neuropathic Pain - Intervention Study on Pregabalin